如瑞迪博士 RDY 深 沪
等待开盘 08-25 09:30:00 美东时间
12.22
+0.040
+0.33%
华盛通- 最 高12.25
- 今 开12.24
- 成交量 206.95万股
- 最 低 12.13
- 昨 收 12.18
- 总市值 101.79亿
- 52周最高 15.6057
- 市盈率 静 21.00
- 换手率 0.25%
- 52周最低 11.2957
- 委 比 -64.71%
- 总股本 8.33亿
- 历史最高 16.7562
- 量 比 0.80
- 振 幅 0.99%
- 历史最低 4.6027
- 每 手 1
- 风险率 0.74%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Why Dr. Reddy's Sank: Profit Plunge, Semaglutide Setback And Trump's Tariff Threat
Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) stock fell Wednesday after the generic drugmaker reported first-quarter fiscal 2027 earnings and revenue that missed Wall Street estimates. Investors also weighed U.S. President Donald Trump’s plan to impose steep tariffs on imported generic drugs over the ne...
07-23 02:12
Dr Reddy's Laboratories Q1 EPS $0.06 Misses $0.17 Estimate, Sales $853.000M Miss $925.530M Estimate
Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.17 by 64.71 percent. This is a 70 percent decrease over earnings of $0.20 per share from the same period last year. The company reported quarterly sales of $853.000 mil...
07-22 19:30
美股夜盘 | Abivax SA Sponsored ADR涨27.41%，航空环境涨19.14%
Abivax SA Sponsored ADR涨27.41%；航空环境涨19.14%；SharonAI Holdings, Inc. Class A涨14.77%
06-30 13:01
美股盘后 | Ares Management Corporation涨5.75%，齐默巴奥米特涨2.31%
Ares Management Corporation涨5.75%；齐默巴奥米特涨2.31%；Krystal Biotech, Inc.涨2.28%
06-19 06:10
Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push
Dr. Reddy's launched generic Semaglutide Injection in Canada, expanding its GLP-1 portfolio and strengthening its affordable diabetes treatment presence.
05-17 03:17
Dr Reddy's Laboratories shares are trading lower after the company reported worse-than-expected Q4 financial results.
Dr Reddy's Laboratories shares are trading lower after the company reported wor...
05-12 22:43
Dr Reddy's Laboratories Q4 EPS $0.03 Misses $0.09 Estimate, Sales $821.821M Miss $866.120M Estimate
Dr Reddy's Laboratories (NYSE:RDY) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.09 by 66.67 percent. This is a 86.36 percent decrease over earnings of $0.22 per share
05-12 19:42
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
'Canada Approves Its First Generic Version of Novo's Ozempic' - Bloomberg News
https://www.bloomberg.com/news/articles/2026-04-28/canada-approves-its-first-generic-version-of-novo-s-ozempic
04-29 05:03
